Flotetuzumab (INN; development code MGD006) is a bispecific antibody designed for the treatment of acute myeloid leukemia.. This drug is being developed by…
Flotetuzumab (INN; development code MGD006) is a bispecific antibody designed for the treatment of acute myeloid leukemia..
This drug is being developed by MacroGenics, Inc.Statement On A Nonproprietary Name Adopted By The USAN Council - Flotetuzumab, American Medical Association.
References
Gebaseerd op: Wikipedia — Flotetuzumab · auteursgeschiedenis.
Tekst: CC BY-SA 4.0.
Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.